Gautam Vaidyanathan's practice is focused on M&A, corporate governance, general corporate and securities matters, and venture capital transactions. He advises public and private companies on domestic and cross-border mergers, acquisitions, and divestitures of all sizes.
Gautam represents clients from a broad range of industries, including biopharmaceutical, medical device, pharmaceutical, technology, energy, telecommunication, and retail. Representative clients include AbbVie, Advantage Solutions, Ambry Genetics, Celgene Corporation, Cylance, Educational Testing Service, the Internet Corporation for Assigned Names and Numbers (ICANN), Grindr, Hitachi Vantara, Hookit (SponsorHouse), Itron, JTC, Linear Technology, Misonix, Sumitomo Dainippon Pharma Co., TDK Corporation, Total, Verimatrix, and Western Digital Corp.
Recent representations include Linear Technology's $14.8 billion sale to Analog Devices; Sumitomo Dainippon Pharma's $3 billion acquisition of late-stage biopharma companies from Roivant Sciences; Cylance's $1.4 billion acquisition of BlackBerry Limited; TDK Corporation's $1.3 billion acquisition of InvenSense; Ambry Genetics' $1 billion sale to Konica Minolta; Itron's $830 million acquisition of Silver Spring Networks; Inside Secure's $145 million acquisition of Verimatrix; Educational Testing Service's $127.5 million acquisition of Questar Assessment; JTC's $116 million acquisition of NES Financial; Misonix's $109 million acquisition of Solsys Medical; Advantage Solutions' acquisitions of The Data Council, Quiverr Collective, and Upshot; and Hookit's raise of capital in its Series C round.
- University of California, Los Angeles (J.D. 2015, with a specialization in Business Law and Policy); University of California, Irvine (B.S. in Business Economics and Political Science 2011)